August 16, 2021 04:59 PM EDTUpdated August 20, 12:43 PM

After the long, grueling path to EUA, Roche says there is a supply shortage of Actemra

Josh Sullivan

Roche’s drug Actemra was granted emergency use authorization by the FDA for Covid-19 despite some mixed data, but an 11,000-patient analysis soon showed it cut …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

After the long, grueling path to EUA, Roche says there is a supply shortage of Actemra

Josh Sullivan

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Af­ter the long, gru­el­ing path to EUA, Roche says there is a sup­ply short­age of Actem­ra

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

After the long, grueling path to EUA, Roche says there is a supply shortage of Actemra